申请人:GILEAD SCIENCES INC
公开号:WO2015179448A1
公开(公告)日:2015-11-26
Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (I): including stereoisomers and pharmaceutically acceptable salts thereof, wherein D, V, and R3 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
本文揭示了用于治疗人类免疫缺陷病毒(HIV)感染的化合物。这些化合物具有以下公式(I):包括立体异构体和药学上可接受的盐,其中D、V和R3的定义如本文所述。本文还揭示了与制备和使用这些化合物相关的方法,以及包括这些化合物的制药组合物。